Quick Takeaways
- This page summarizes Roger E. Susi's Form 4 filing for IRADIMED CORP (IRMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 08 Apr 2022, 16:08.
Roger E. Susi - 07 Apr 2022 Form 4 Insider Report for IRADIMED CORP (IRMD)
- Signature
- /s/ Roger E. Susi
- Issuer symbol
- IRMD
- Transactions as of
- 07 Apr 2022
- Net transactions value
- -$453,530
- Form type
- 4
- Filing time
- 08 Apr 2022, 16:08:23 UTC
- Previous filing
- 30 Mar 2022
- Next filing
- 13 Apr 2022
- SEC
- View on sec.gov
Quoteable Key Fact
"Roger E. Susi filed Form 4 for IRADIMED CORP (IRMD) on 08 Apr 2022."
What Changed
- Previous filing in this sequence was filed on 30 Mar 2022.
- Current net transaction value: -$453,530.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
IRMD
transaction
Common Stock
Sale
- Transaction value
- $453,530
- Shares
- -10,000
- Change %
- -1.5%
- Price
- $45.35
- Shares after
- 662,950
- Date
- 07 Apr 2022
- Ownership
- By Roger E. Susi Revocable Trust
- Footnotes
- F1, F2
IRMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,362,500
- Date
- 07 Apr 2022
- Ownership
- By Matthew Susi 2008 Dynasty Trust
- Footnotes
- F3
IRMD
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 2,362,500
- Date
- 07 Apr 2022
- Ownership
- By Phillip Susi 2008 Dynasty Trust
- Footnotes
- F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 15, 2021. |
| F2 | This transaction was executed in multiple trades at prices ranging from $44.50 to $45.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose. |